Lista de obras - Katherine R. Calvo - Dominio Público Uruguay

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

artículo científico publicado en 2014

Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.

artículo científico publicado en 2018

Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.

artículo científico publicado en 2013

An immune-based biomarker signature is associated with mortality in COVID-19 patients

artículo científico publicado en 2020

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

artículo científico publicado en 2015

Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial

scientific article published on 18 September 2013

Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation

artículo científico publicado en 2011

Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis

scientific article published on 01 January 2006

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia

artículo científico publicado en 2013

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

artículo científico publicado en 2005

Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

artículo científico publicado en 2013

Donor-derived MDS/AML in families with germline GATA2 mutation

scientific article published on 19 September 2018

Early-onset stroke and vasculopathy associated with mutations in ADA2

artículo científico publicado en 2014

Effect of viral decontamination measures on Wright-stained blood smears.

artículo científico publicado en 2015

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

artículo científico publicado en 2013

Feasibility and safety of sequential research-related tumor core biopsies in clinical trials

artículo científico publicado en 2012

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.

artículo científico publicado en 2014

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

artículo científico publicado en 2013

Hairy cell leukemia coexistent with chronic lymphocytic leukemia

scientific article published on 01 March 2019

Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression

artículo científico publicado en 2000

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

artículo científico publicado en 2014

Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia

artículo científico publicado en 2019

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

artículo científico publicado en 2015

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

artículo científico publicado en 2021

Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.

artículo científico publicado en 2013

Mastocytosis: the new differential diagnosis of CD30-positive neoplasms

scientific article published on 04 April 2011

Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion

artículo científico publicado en 2012

Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma

artículo científico publicado en 2004

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

artículo científico publicado en 2011

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency

artículo científico publicado en 2014

Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1

artículo científico publicado en 2002

Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis

artículo científico publicado en 2021

Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids.

artículo científico publicado en 2007

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

artículo científico publicado en 2009

Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma

artículo científico publicado en 2011

Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance

artículo científico publicado en 2020

Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

artículo científico publicado en 2011

Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.

artículo científico publicado en 2013

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

artículo científico publicado en 2015

Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.

artículo científico publicado en 2010

Lista de obras de Katherine R. Calvo

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.

Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial

Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation

Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

Donor-derived MDS/AML in families with germline GATA2 mutation

Early-onset stroke and vasculopathy associated with mutations in ADA2

Effect of viral decontamination measures on Wright-stained blood smears.

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Feasibility and safety of sequential research-related tumor core biopsies in clinical trials

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

Hairy cell leukemia coexistent with chronic lymphocytic leukemia

Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.

Mastocytosis: the new differential diagnosis of CD30-positive neoplasms

Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion

Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency

Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1

Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis

Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids.

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma

Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance

Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.